Trinity College Dublin and ProVerum Ltd

ProVerum is developing a medical device to assist older men with benign prostatic hyperplasia, a common bladder condition in men over 50. The company employs 25 people and announced Series A funding of €30 million in January this year, positioning itself for significant future growth.